Skip to main content
Clinical Trials/ISRCTN57474502
ISRCTN57474502Completed未知

Comparative effectiveness of magnetic resonance (MR) imaging in women with breast cancer

Hull and East Yorkshire Hospitals NHS Trust (UK)0 sites1,623 target enrollmentStarted: June 19, 2002Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
1,623

Study Overview

Brief Summary

2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20025837 results on cost effectiveness 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20159292 results on clinical effectiveness

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • Patients scheduled for wide local excision for primary breast cancer

Exclusion Criteria

  • Added as of 10/06/2008:
  • 1. Medically unstable
  • 2. Known contraindication to magnetic resonance (MR) scanning
  • 3. Known to have had an allergic reaction associated with previous administration of paramagnetic contrast agent or have a severe allergic diathesis
  • 4. Require renal dialysis
  • 5. Have undergone chemotherapy/ hormonal therapy for cancer of the contralateral breast (or other sites) in the previous 12 months or have chemotherapy planned to any site before their breast surgery
  • 6. Have had surgery or radiotherapy for cancer to the ipsilateral breast
  • 7. Have had surgery to the ipsilateral breast within the previous 4 months for benign breast disease
  • 8. Have a history of serious breast trauma within the last 3 months
  • 9. Pregnant or breast feeding
  • 10. Disability preventing MR scanning in the prone position
  • 11. Under the care of a breast surgeon recruiting into the ALMANAC Trial

Investigators

Sponsor
Hull and East Yorkshire Hospitals NHS Trust (UK)

Similar Trials